Compare BURL & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BURL | BAX |
|---|---|---|
| Founded | 1972 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.8B | 9.4B |
| IPO Year | 2013 | N/A |
| Metric | BURL | BAX |
|---|---|---|
| Price | $263.88 | $19.01 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 16 | 10 |
| Target Price | ★ $336.57 | $25.67 |
| AVG Volume (30 Days) | 1.3M | ★ 7.9M |
| Earning Date | 11-25-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 0.21% |
| EPS Growth | ★ 19.59 | N/A |
| EPS | ★ 8.72 | N/A |
| Revenue | ★ $11,187,977,000.00 | $11,023,000,000.00 |
| Revenue This Year | $9.78 | $5.20 |
| Revenue Next Year | $9.68 | $2.02 |
| P/E Ratio | $30.53 | ★ N/A |
| Revenue Growth | ★ 6.81 | 3.90 |
| 52 Week Low | $212.92 | $17.40 |
| 52 Week High | $309.00 | $37.74 |
| Indicator | BURL | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 48.96 | 52.32 |
| Support Level | $261.25 | $17.92 |
| Resistance Level | $275.88 | $19.17 |
| Average True Range (ATR) | 10.62 | 0.44 |
| MACD | 0.92 | 0.18 |
| Stochastic Oscillator | 46.64 | 85.56 |
Burlington Stores Inc is off-price retailer offering an extensive selection of in-season, fashion-focused merchandise including: women's ready-to-wear apparel, menswear, youth apparel, baby, beauty, footwear, accessories, home, toys, gifts and coats. Company sell a broad selection of desirable, first-quality, current-brand, labeled merchandise acquired directly from nationally recognized manufacturers and other suppliers. Company sell product in category such as Ladies apparel, Accessories and shoes, Home, Mens apparel, Kids apparel and baby and Outerwear.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.